This article is more than 5 years old. Information may no longer be current.

FDA approves generic equivalent of Cutivate Lotion

The FDA has granted approval for an abbreviated new drug application for fluticasone propionate lotion, 0.05%, the generic equivalent to Cutivate Lotion, 0.05%, manufacturer Perrigo Co. announced.

Fluticasone propionate lotion is indicated for relief of inflammatory and pruritic manifestations caused by atopic dermatitis in patients aged 1 year or older, according to a press release. Perrigo announced that shipment of its product will begin immediately.

PharmaDerm manufactures Cutivate Lotion.